p21ras	B-protein
initiates	O
Rac-1	B-protein
but	O
not	O
phosphatidyl	B-protein
inositol	I-protein
3	I-protein
kinase/PKB	I-protein
,	O
mediated	O
signaling	O
pathways	O
in	O
T	B-cell_type
lymphocytes	I-cell_type
.	O

p21ras	B-protein
is	O
activated	O
by	O
the	O
T	B-protein
cell	I-protein
antigen	I-protein
receptor	I-protein
(	O
TCR	B-protein
)	O
and	O
then	O
co-ordinates	O
important	O
signaling	O
pathways	O
for	O
T	B-protein
lymphocyte	I-protein
activation	O
.	O

Effector	O
pathways	O
for	O
this	O
guanine	B-protein
nucleotide	I-protein
binding	I-protein
protein	I-protein
in	O
T	B-cell_type
cells	I-cell_type
are	O
mediated	O
by	O
the	O
serine/threonine	B-protein
kinase	I-protein
Raf-1	B-protein
and	O
the	O
Ras-related	B-protein
GTPase	I-protein
Rac-1	B-protein
.	O

In	O
fibroblasts	B-cell_type
,	O
an	O
important	O
effector	O
for	O
the	O
Ras	B-DNA
oncogene	I-DNA
is	O
Phosphatidylinositol	B-protein
3-kinase	I-protein
(	O
PtdIns	B-protein
3-kinase	I-protein
)	O
.	O

Activation	O
of	O
this	O
lipid	B-protein
kinase	I-protein
is	O
able	O
to	O
induce	O
critical	O
Rac-1	B-protein
signaling	O
pathways	O
and	O
can	O
couple	O
p21ras	B-protein
to	O
cell	O
survival	O
mechanisms	O
via	O
the	O
serine/threonine	B-protein
kinase	I-protein
Akt/PKB	I-protein
.	O

The	O
role	O
of	O
PtdIns	B-protein
3-kinase	I-protein
in	O
Ras	B-protein
signaling	O
in	O
T	B-cell_type
cells	I-cell_type
has	O
not	O
been	O
explored	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
examined	O
the	O
ability	O
of	O
PtdIns	B-protein
3-kinase	I-protein
to	O
initiate	O
the	O
Rac-1	B-protein
signaling	O
pathways	O
important	O
for	O
T	O
cell	O
activation	O
.	O

We	O
also	O
examined	O
the	O
possibility	O
that	O
Akt/PKB	B-protein
is	O
regulated	O
by	O
Ras	O
signaling	O
pathways	O
in	O
T	B-cell_type
lymphocytes	I-cell_type
.	O

The	O
results	O
show	O
that	O
Ras	B-protein
can	O
initiate	O
a	O
Rac-1	B-protein
mediated	O
pathway	O
that	O
regulates	O
the	O
transcriptional	O
function	O
of	O
AP-1	B-protein
complexes	I-protein
.	O

PtdIns	B-protein
3-kinase	I-protein
signals	O
can	O
not	O
mimic	O
p21ras	B-protein
and	O
induce	O
the	O
Rac	B-protein
mediated	O
responses	O
of	O
AP-1	B-protein
transcriptional	O
activation	O
.	O

Moreover	O
,	O
neither	O
TCR	B-protein
or	O
Ras	B-protein
activation	O
of	O
AP-1	B-protein
is	O
dependent	O
on	O
PtdIns	B-protein
3-kinase	I-protein
.	O

PKB	B-protein
is	O
activated	O
in	O
response	O
to	O
triggering	O
of	O
the	O
T	B-protein
cell	I-protein
antigen	I-protein
receptor	I-protein
;	O
PtdIns	B-protein
3-kinase	I-protein
activity	O
is	O
both	O
required	O
and	O
sufficient	O
for	O
this	O
TCR	B-protein
response	O
.	O

In	O
contrast	O
,	O
p21ras	B-protein
signals	O
are	O
unable	O
to	O
induce	O
Akt/PKB	B-protein
activity	O
in	O
T	B-cell_type
cell	I-cell_type
nor	O
is	O
Ras	B-protein
function	O
required	O
for	O
Akt/PKB	B-protein
activation	O
in	O
response	O
to	O
the	O
TCR	B-protein
.	O

The	O
present	O
data	O
thus	O
highlight	O
that	O
PtdIns	B-protein
3-kinase	I-protein
and	O
Akt/PKB	B-protein
are	O
not	O
universal	O
Ras	B-protein
effector	I-protein
molecules	I-protein
.	O

Ras	B-protein
can	O
initiate	O
Rac-1	B-protein
regulated	O
signaling	O
pathways	O
in	O
the	O
context	O
of	O
T	B-protein
cell	I-protein
antigen	I-protein
receptor	I-protein
function	O
independently	O
of	O
PtdIns	B-protein
3-kinase	I-protein
activity	O
.	O

Oncogene	NULL
(	NULL
1998	NULL
)	NULL
17	NULL
,	NULL
1731-1738	NULL
Â©	NULL
1998	NULL
Stockton	NULL
Press	NULL
All	NULL
rights	NULL
reserved	NULL
0950-9232/98	NULL
$	NULL
12.00	NULL
http	NULL
:	NULL
//www	NULL
.	NULL

stockton-press.co.uk/onc	NULL
p21lras	NULL
initiates	NULL
Rac-1	NULL
but	NULL
not	NULL
phosphatidyl	NULL
inositol	NULL
3	NULL
kinase/PKB	NULL
,	NULL
mediated	NULL
signaling	NULL
pathways	NULL
in	NULL
T	NULL
lymphocytes	NULL
Elisabeth	NULL
Genot	NULL
,	NULL
Karin	NULL
Reif	NULL
,	NULL
Sarah	NULL
Beach	NULL
'	NULL
,	NULL
Ijsbrand	NULL
Kramer	NULL
and	NULL
Doreen	NULL
Cantrell	NULL
'	NULL
'Lymphocyte	NULL
Activation	NULL
Laboratory	NULL
,	NULL
Imperial	NULL
Cancer	NULL
Research	NULL
Fund	NULL
,	NULL
44	NULL
Lincoln	NULL
's	NULL
Inn	NULL
Fields	NULL
,	NULL
London	NULL
WC2A	NULL
3PX	NULL
,	NULL
UK	NULL
;	NULL
*Department	NULL
of	NULL
Pharmacology	NULL
,	NULL
University	NULL
College	NULL
London	NULL
,	NULL
Gower	NULL
Street	NULL
,	NULL
London	NULL
WCIE	NULL
6BT	NULL
p2lras	NULL
is	NULL
activated	NULL
by	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
and	NULL
then	NULL
co-ordinates	NULL
important	NULL
signaling	NULL
pathways	NULL
for	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Effector	NULL
pathways	NULL
for	NULL
this	NULL
guanine	NULL
nucleotide	NULL
binding	NULL
protein	NULL
in	NULL
T	NULL
cells	NULL
are	NULL
mediated	NULL
by	NULL
the	NULL
serine/threonine	NULL
kinase	NULL
Raf-1	NULL
and	NULL
the	NULL
Ras-related	NULL
GTPase	NULL
Rac-1	NULL
.	NULL

In	NULL
fibroblasts	NULL
,	NULL
an	NULL
important	NULL
effector	NULL
for	NULL
the	NULL
Ras	NULL
oncogene	NULL
is	NULL
Phosphatidylinositol	NULL
3-kinase	NULL
(	NULL
PtdIns	NULL
3-kinase	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
this	NULL
lipid	NULL
kinase	NULL
is	NULL
able	NULL
to	NULL
induce	NULL
critical	NULL
Rac-1	NULL
signaling	NULL
pathways	NULL
and	NULL
can	NULL
couple	NULL
p2lras	NULL
to	NULL
cell	NULL
survival	NULL
mechanisms	NULL
via	NULL
the	NULL
serine/threonine	NULL
kinase	NULL
Akt/PKB	NULL
.	NULL

The	NULL
role	NULL
of	NULL
PtdIns	NULL
3-kinase	NULL
in	NULL
Ras	NULL
signaling	NULL
in	NULL
T	NULL
cells	NULL
has	NULL
not	NULL
been	NULL
explored	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
ability	NULL
of	NULL
PtdIns	NULL
3-kinase	NULL
to	NULL
initiate	NULL
the	NULL
Rac-1	NULL
signaling	NULL
pathways	NULL
important	NULL
for	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

We	NULL
also	NULL
examined	NULL
the	NULL
possibility	NULL
that	NULL
Akt/PKB	NULL
is	NULL
regulated	NULL
by	NULL
Ras	NULL
signaling	NULL
pathways	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
Ras	NULL
can	NULL
initiate	NULL
a	NULL
Rac-1	NULL
mediated	NULL
pathway	NULL
that	NULL
regulates	NULL
the	NULL
transcriptional	NULL
function	NULL
of	NULL
AP-1	NULL
complexes	NULL
.	NULL

PtdIns	NULL
3-kinase	NULL
signals	NULL
can	NULL
not	NULL
mimic	NULL
p21lras	NULL
and	NULL
induce	NULL
the	NULL
Rac	NULL
mediated	NULL
responses	NULL
of	NULL
AP-1	NULL
transcriptional	NULL
activation	NULL
.	NULL

Moreover	NULL
,	NULL
neither	NULL
TCR	NULL
or	NULL
Ras	NULL
activation	NULL
of	NULL
AP-1	NULL
is	NULL
dependent	NULL
on	NULL
PtdIns	NULL
3-kinase	NULL
.	NULL

PKB	NULL
is	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
triggering	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
;	NULL
PtdIns	NULL
3-kinase	NULL
activity	NULL
is	NULL
both	NULL
required	NULL
and	NULL
sufficient	NULL
for	NULL
this	NULL
TCR	NULL
response	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
p2lras	NULL
signals	NULL
are	NULL
unable	NULL
to	NULL
induce	NULL
Akt/PKB	NULL
activity	NULL
in	NULL
T	NULL
cell	NULL
nor	NULL
is	NULL
Ras	NULL
function	NULL
required	NULL
for	NULL
Akt/PKB	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
the	NULL
TCR	NULL
.	NULL

The	NULL
present	NULL
data	NULL
thus	NULL
highlight	NULL
that	NULL
PtdIns	NULL
3-kinase	NULL
and	NULL
Akt/PKB	NULL
are	NULL
not	NULL
universal	NULL
Ras	NULL
effector	NULL
molecules	NULL
.	NULL

Ras	NULL
can	NULL
initiate	NULL
Rac-1	NULL
regulated	NULL
signaling	NULL
pathways	NULL
in	NULL
the	NULL
context	NULL
of	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
function	NULL
independently	NULL
of	NULL
PtdIns	NULL
3-kinase	NULL
activity	NULL
.	NULL

Keywords	NULL
:	NULL
p2lras	NULL
;	NULL
Akt/PKB	NULL
;	NULL
signalling	NULL
pathways	NULL
;	NULL
T	NULL
cells	NULL
Introduction	NULL
p2lras	NULL
functions	NULL
as	NULL
a	NULL
molecular	NULL
switch	NULL
in	NULL
activating	NULL
downstream	NULL
effector	NULL
pathways	NULL
that	NULL
control	NULL
growth	NULL
and	NULL
Correspondence	NULL
:	NULL
E	NULL
Genot	NULL
Current	NULL
addresses	NULL
:	NULL
*Department	NULL
of	NULL
Immunology	NULL
,	NULL
Imperial	NULL
College	NULL
,	NULL
Hammersmith	NULL
Hospital	NULL
,	NULL
Du	NULL
Cane	NULL
Road	NULL
,	NULL
London	NULL
W12	NULL
ONN	NULL
,	NULL
UK	NULL
*Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
513	NULL
Parnassus	NULL
,	NULL
Box	NULL
0414	NULL
,	NULL
Rm	NULL
HSE301	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
California	NULL
94143-0414	NULL
,	NULL
USA	NULL
Received	NULL
9	NULL
September	NULL
1997	NULL
;	NULL
revised	NULL
5	NULL
May	NULL
1998	NULL
;	NULL
accepted	NULL
5	NULL
May	NULL
1998	NULL
differentiation	NULL
.	NULL

This	NULL
guanine	NULL
nucleotide	NULL
binding	NULL
protein	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
T	NULL
lymphocyte	NULL
activation	NULL
by	NULL
coupling	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
to	NULL
the	NULL
signaling	NULL
pathways	NULL
that	NULL
regulate	NULL
the	NULL
activity	NULL
of	NULL
transcription	NULL
factors	NULL
important	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
cytokine	NULL
genes	NULL
(	NULL
Cantrell	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

These	NULL
include	NULL
the	NULL
ETS	NULL
family	NULL
protein	NULL
Elk-1	NULL
,	NULL
the	NULL
serum	NULL
response	NULL
factor	NULL
(	NULL
SRF	NULL
)	NULL
,	NULL
API	NULL
and	NULL
Nuclear	NULL
Factor	NULL
of	NULL
Activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
(	NULL
Genot	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Woodrow	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

p2lras	NULL
signals	NULL
are	NULL
also	NULL
important	NULL
for	NULL
thymocyte	NULL
development	NULL
and	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
regulate	NULL
the	NULL
positive	NULL
selection	NULL
of	NULL
thymocytes	NULL
(	NULL
Swan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
Raf-1/MEK/	NULL
Erk2	NULL
pathway	NULL
is	NULL
one	NULL
effector	NULL
system	NULL
for	NULL
p2lras	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
Izquierdo	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1993	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

However	NULL
,	NULL
other	NULL
Ras	NULL
effector	NULL
pathways	NULL
must	NULL
exist	NULL
in	NULL
lymphocytes	NULL
.	NULL

For	NULL
example	NULL
,	NULL
activation	NULL
of	NULL
MEK	NULL
is	NULL
not	NULL
required	NULL
for	NULL
TCR	NULL
induced	NULL
proliferative	NULL
responses	NULL
of	NULL
mature	NULL
thymocytes	NULL
whereas	NULL
p21ras	NULL
signals	NULL
are	NULL
indispensable	NULL
(	NULL
Alberola-Ila	NULL
,	NULL
1996	NULL
;	NULL
Alberola-Ila	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
signals	NULL
generated	NULL
by	NULL
activated	NULL
p2lras	NULL
but	NULL
not	NULL
MEK	NULL
are	NULL
sufficient	NULL
to	NULL
induce	NULL
the	NULL
transition	NULL
of	NULL
Rag-/-thymocytes	NULL
from	NULL
CD4/CD8	NULL
double	NULL
negative	NULL
to	NULL
CD4/	NULL
CD8	NULL
double	NULL
positive	NULL
status	NULL
(	NULL
Crompton	NULL
,	NULL
1996	NULL
;	NULL
Swat	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
MEK	NULL
pathway	NULL
can	NULL
efficiently	NULL
couple	NULL
the	NULL
TCR	NULL
to	NULL
the	NULL
Erk2	NULL
pathway	NULL
but	NULL
this	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
p2lras	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
API	NULL
or	NULL
NFAT	NULL
(	NULL
Genot	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
in	NULL
mast	NULL
cells	NULL
activation	NULL
of	NULL
Erk1/2	NULL
MAP	NULL
kinases	NULL
is	NULL
is	NULL
not	NULL
required	NULL
for	NULL
FcsR1l	NULL
regulation	NULL
of	NULL
NFAT	NULL
at	NULL
all	NULL
,	NULL
although	NULL
activation	NULL
of	NULL
Ras	NULL
is	NULL
essential	NULL
(	NULL
Genot	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Turner	NULL
and	NULL
Cantrell	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
highlight	NULL
that	NULL
lymphocyte	NULL
activation	NULL
involves	NULL
the	NULL
coordinated	NULL
action	NULL
of	NULL
multiple	NULL
Ras	NULL
effector	NULL
pathways	NULL
.	NULL

A	NULL
strong	NULL
candidate	NULL
for	NULL
regulating	NULL
Ras	NULL
effector	NULL
pathways	NULL
in	NULL
haematopoietic	NULL
cells	NULL
is	NULL
the	NULL
Rho	NULL
family	NULL
GTPase	NULL
Rac-1	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
Rac-1	NULL
couples	NULL
p2lras	NULL
to	NULL
the	NULL
signaling	NULL
pathways	NULL
that	NULL
induce	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
API	NULL
and	NULL
NFAT	NULL
(	NULL
Genot	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Turner	NULL
and	NULL
Cantrell	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
Rac-1	NULL
in	NULL
Ras	NULL
responses	NULL
in	NULL
lymphocytes	NULL
has	NULL
clear	NULL
parallels	NULL
with	NULL
studies	NULL
in	NULL
fibroblasts	NULL
where	NULL
it	NULL
is	NULL
evident	NULL
that	NULL
signaling	NULL
networks	NULL
mediated	NULL
by	NULL
Rho-family	NULL
GTPases	NULL
such	NULL
as	NULL
Rac-1	NULL
and	NULL
RhoA	NULL
(	NULL
Qiu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995a	NULL
,	NULL
b	NULL
;	NULL
Westwick	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
are	NULL
important	NULL
for	NULL
Ras	NULL
induction	NULL
of	NULL
cell	NULL
transformation	NULL
and	NULL
DNA	NULL
synthesis	NULL
.	NULL

In	NULL
fibroblasts	NULL
there	NULL
has	NULL
been	NULL
some	NULL
characterisation	NULL
of	NULL
the	NULL
mechanism	NULL
that	NULL
couples	NULL
p21lras	NULL
to	NULL
the	NULL
GTPase	NULL
Rac-1	NULL
:	NULL
notably	NULL
,	NULL
one	NULL
key	NULL
p2lras	NULL
effector	NULL
molecule	NULL
is	NULL
PtdIns	NULL
3-kinase	NULL
which	NULL
binds	NULL
directly	NULL
to	NULL
active	NULL
GTP	NULL
bound	NULL
p21lras	NULL
resulting	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
lipid	NULL
kinase	NULL
(	NULL
Rodriguez-Viciana	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
PH	NULL
domains	NULL
of	NULL
Rac/	NULL
Rho	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
proteins	NULL
(	NULL
GEFs	NULL
)	NULL
Ras	NULL
effector	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
E	NULL
Genot	NULL
et	NULL
al	NULL
1732	NULL
selectively	NULL
bind	NULL
polyphosphoinositides	NULL
particularily	NULL
PI	NULL
(	NULL
3,4,5	NULL
)	NULL
P	NULL
;	NULL
,	NULL
a	NULL
product	NULL
of	NULL
PtdIns	NULL
3-kinase	NULL
activity	NULL
(	NULL
Rameh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

It	NULL
is	NULL
thought	NULL
that	NULL
binding	NULL
of	NULL
these	NULL
lipid	NULL
products	NULL
of	NULL
PItdIns	NULL
3-kinase	NULL
to	NULL
PH	NULL
domains	NULL
of	NULL
Rac/Rho	NULL
GEFs	NULL
either	NULL
allosterically	NULL
modifies	NULL
GEF	NULL
activity	NULL
,	NULL
or	NULL
induces	NULL
relocalization	NULL
of	NULL
the	NULL
protein	NULL
to	NULL
specific	NULL
subcellular	NULL
locations	NULL
or	NULL
defined	NULL
areas	NULL
of	NULL
the	NULL
plasma	NULL
membrane	NULL
where	NULL
activation	NULL
can	NULL
occur	NULL
.	NULL

PtdIns	NULL
3-kinase	NULL
signals	NULL
can	NULL
couple	NULL
p21ras	NULL
to	NULL
a	NULL
Rac-1	NULL
mediated	NULL
pathway	NULL
that	NULL
controls	NULL
the	NULL
cortical	NULL
actin	NULL
cytoskeleton	NULL
and	NULL
cell	NULL
transformation	NULL
(	NULL
Kauffmann-Zeh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Reif	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Rodriguez-Viciana	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Wennstrom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

PtdIns	NULL
3-kinase	NULL
also	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
coupling	NULL
p21lras	NULL
to	NULL
a	NULL
second	NULL
distinct	NULL
effector	NULL
pathway	NULL
mediated	NULL
by	NULL
the	NULL
serine/	NULL
threonine	NULL
kinase	NULL
Akt/PKB	NULL
(	NULL
Burgering	NULL
and	NULL
Coffer	NULL
,	NULL
1995	NULL
;	NULL
Klippel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Marte	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Akt/	NULL
PKB	NULL
was	NULL
originally	NULL
identified	NULL
as	NULL
the	NULL
cellular	NULL
homologue	NULL
of	NULL
the	NULL
transforming	NULL
oncogene	NULL
of	NULL
the	NULL
murine	NULL
retrovirus	NULL
AKT8	NULL
,	NULL
which	NULL
causes	NULL
thymic	NULL
lymphomas	NULL
(	NULL
Staal	NULL
and	NULL
Hartley	NULL
,	NULL
1988	NULL
)	NULL
.	NULL

This	NULL
oncogene	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
Ras	NULL
maintenance	NULL
of	NULL
cell	NULL
survival	NULL
(	NULL
Kauffmann-Zeh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Cooperative	NULL
interactions	NULL
between	NULL
Akt/PKB	NULL
and	NULL
Rac-1	NULL
and	NULL
Raf-1/MEK	NULL
signaling	NULL
pathways	NULL
are	NULL
required	NULL
for	NULL
Ras	NULL
induction	NULL
of	NULL
DNA	NULL
synthesis	NULL
and	NULL
cell	NULL
transformation	NULL
(	NULL
Rodriguez-Viciana	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

By	NULL
analogy	NULL
with	NULL
fibroblast	NULL
studies	NULL
,	NULL
PtdIns	NULL
3-kinase	NULL
is	NULL
a	NULL
possible	NULL
candidate	NULL
to	NULL
couple	NULL
p2lras	NULL
to	NULL
the	NULL
Rac	NULL
signaling	NULL
pathways	NULL
important	NULL
for	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Similarly	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
Akt/PKB	NULL
could	NULL
be	NULL
activated	NULL
by	NULL
Ras	NULL
induced	NULL
signaling	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
yet	NULL
known	NULL
whether	NULL
there	NULL
are	NULL
universal	NULL
Ras	NULL
signaling	NULL
pathways	NULL
that	NULL
operate	NULL
in	NULL
every	NULL
cell	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
previously	NULL
that	NULL
PtdIns	NULL
3-kinase	NULL
can	NULL
only	NULL
induce	NULL
a	NULL
subset	NULL
of	NULL
Rac	NULL
mediated	NULL
cellular	NULL
responses	NULL
in	NULL
fibroblasts	NULL
(	NULL
Reif	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
so	NULL
it	NULL
should	NULL
not	NULL
be	NULL
assumed	NULL
that	NULL
PtdIns	NULL
3-kinase	NULL
will	NULL
couple	NULL
Ras	NULL
to	NULL
the	NULL
Rac	NULL
mediated	NULL
responses	NULL
required	NULL
for	NULL
T	NULL
cell	NULL
transcription	NULL
factor	NULL
responses	NULL
.	NULL

Similarily	NULL
,	NULL
it	NULL
is	NULL
not	NULL
yet	NULL
known	NULL
whether	NULL
p21lras	NULL
activation	NULL
of	NULL
Akt/PKB	NULL
is	NULL
a	NULL
ubiquitous	NULL
response	NULL
that	NULL
occurs	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
.	NULL

AkUPKB	NULL
kinase	NULL
activity	NULL
(	NULL
fold	NULL
increase	NULL
)	NULL
kinase	NULL
activity	NULL
(	NULL
fold	NULL
increase	NULL
)	NULL
empty	NULL
v-Ha-ras	NULL
empty	NULL
v-Ha-ras	NULL
S	NULL
yet	NULL
a	NULL
A	NULL
&	NULL
``	NULL
D2pL1OR/P	NULL
We	NULL
were	NULL
thus	NULL
interested	NULL
to	NULL
explore	NULL
two	NULL
questions	NULL
in	NULL
T	NULL
cells	NULL
:	NULL
First	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
p21ras	NULL
to	NULL
stimulate	NULL
Akt/PKB	NULL
;	NULL
second	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
PtdIns	NULL
3-kinase	NULL
to	NULL
initiate	NULL
Rac	NULL
mediated	NULL
effector	NULL
pathways	NULL
.	NULL

These	NULL
questions	NULL
address	NULL
an	NULL
important	NULL
issue	NULL
;	NULL
are	NULL
current	NULL
models	NULL
for	NULL
Ras	NULL
signaling	NULL
pathways	NULL
established	NULL
in	NULL
fibroblast	NULL
model	NULL
systems	NULL
universally	NULL
valid	NULL
?	NULL

Results	NULL
PtdIns	NULL
3-kinase	NULL
signals	NULL
but	NULL
not	NULL
p2lras	NULL
can	NULL
regulate	NULL
Akt/	NULL
PKB	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
Expression	NULL
of	NULL
constitutively	NULL
active	NULL
p2lras	NULL
results	NULL
in	NULL
stimulation	NULL
of	NULL
the	NULL
kinase	NULL
activity	NULL
of	NULL
Akt/PKB	NULL
in	NULL
fibroblasts	NULL
and	NULL
epithelial	NULL
cells	NULL
,	NULL
indicating	NULL
that	NULL
Akt/	NULL
PKB	NULL
is	NULL
a	NULL
downstream	NULL
effector	NULL
for	NULL
p2lras	NULL
.	NULL

PtdIns	NULL
3-kinase	NULL
signals	NULL
are	NULL
also	NULL
sufficient	NULL
to	NULL
stimulate	NULL
Akt/PKB	NULL
activity	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
described	NULL
that	NULL
Akt/PKB	NULL
is	NULL
activated	NULL
by	NULL
PtdIns	NULL
3-kinase	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
Reif	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
and	NULL
we	NULL
were	NULL
prompted	NULL
to	NULL
query	NULL
whether	NULL
Akt/PKB	NULL
is	NULL
an	NULL
effector	NULL
common	NULL
to	NULL
both	NULL
PtdIns	NULL
3-kinase	NULL
and	NULL
p21lras	NULL
in	NULL
T	NULL
cells	NULL
We	NULL
therefore	NULL
compared	NULL
the	NULL
ability	NULL
of	NULL
constitutively	NULL
active	NULL
mutants	NULL
of	NULL
p2lras	NULL
and	NULL
PtdIns	NULL
3-kinase	NULL
to	NULL
stimulate	NULL
Akt/PKB	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
classical	NULL
PtdIns	NULL
3-kinase	NULL
comprises	NULL
a	NULL
regulatory	NULL
p85	NULL
and	NULL
a	NULL
catalytic	NULL
pl10	NULL
subunit	NULL
(	NULL
Panayotou	NULL
and	NULL
Waterfield	NULL
,	NULL
1992	NULL
)	NULL
that	NULL
phosphorylates	NULL
-	NULL
PtdIns	NULL
(	NULL
4,5	NULL
)	NULL
P	NULL
;	NULL
-	NULL
generating	NULL
-	NULL
PtdIns	NULL
(	NULL
3,4,5	NULL
)	NULL
P	NULL
;	NULL
,	NULL
and	NULL
its	NULL
derivatives	NULL
The	NULL
dissection	NULL
of	NULL
the	NULL
role	NULL
of	NULL
PtdIns	NULL
3-kinase	NULL
in	NULL
p21lras	NULL
signaling	NULL
in	NULL
fibroblasts	NULL
has	NULL
been	NULL
accelerated	NULL
because	NULL
of	NULL
the	NULL
availability	NULL
of	NULL
a	NULL
membrane	NULL
targeted	NULL
,	NULL
constitutively	NULL
active	NULL
,	NULL
PtdIns	NULL
3-kinase	NULL
.	NULL

A	NULL
chimeric	NULL
protein	NULL
of	NULL
the	NULL
extracellular	NULL
and	NULL
transmembrane	NULL
domain	NULL
of	NULL
the	NULL
rat	NULL
CD2	NULL
marker	NULL
(	NULL
rCD2	NULL
)	NULL
fused	NULL
with	NULL
the	NULL
pl1l0	NULL
Â«	NULL
catalytic	NULL
subunit	NULL
of	NULL
PtdIns	NULL
3-kinase	NULL
(	NULL
rCD2p1l10	NULL
)	NULL
targets	NULL
the	NULL
enzyme	NULL
to	NULL
the	NULL
plasma	NULL
membrane	NULL
generating	NULL
a	NULL
constitutively	NULL
active	NULL
PtdIns	NULL
3-kinase	NULL
that	NULL
induces	NULL
accumulation	NULL
of	NULL
PtdIns	NULL
(	NULL
3,4	NULL
)	NULL
P	NULL
;	NULL
and	NULL
PtdIns	NULL
(	NULL
3,4,5	NULL
)	NULL
P	NULL
;	NULL
in	NULL
W.B	NULL
.	NULL

H2B	NULL
empty	NULL
.	NULL

cite	NULL
*	NULL
%	NULL
%	NULL
@	NULL
N17Ras	NULL
-	NULL
Â¥	NULL
#	NULL
t	NULL
-	NULL
dt	NULL
LY	NULL
294002	NULL
mo	NULL
t	NULL
o-	NULL
oF	NULL
o-	NULL
Ko-	NULL
oto	NULL
-	NULL
#	NULL
5Â°	NULL
10Â°	NULL
5	NULL
10Â°	NULL
control	NULL
UCHTI	NULL
Pdbu	NULL
Figure	NULL
1	NULL
(	NULL
a	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
HA-Akt/PKB	NULL
and	NULL
10	NULL
ug	NULL
of	NULL
various	NULL
plasmid	NULL
encoding	NULL
v-Ha-ras	NULL
,	NULL
rCD2p110	NULL
or	NULL
rCD2p11OR/P	NULL
as	NULL
indicated	NULL
.	NULL

At	NULL
18	NULL
h	NULL
after	NULL
the	NULL
transfection	NULL
,	NULL
HA-akt	NULL
was	NULL
precipitated	NULL
from	NULL
lysates	NULL
with	NULL
12CAS	NULL
antibodies	NULL
and	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
expressed	NULL
kinase	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
immune	NULL
complex	NULL
kinase	NULL
assay	NULL
using	NULL
H2B	NULL
as	NULL
a	NULL
substrate	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
as	NULL
mean	NULL
+s.d	NULL
.	NULL

of	NULL
five	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
myc-Erk2	NULL
and	NULL
10	NULL
ug	NULL
of	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
the	NULL
plasmid	NULL
encoding	NULL
v-Ha-ras	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
harvested	NULL
after	NULL
18	NULL
h	NULL
and	NULL
Erk2	NULL
activity	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
as	NULL
mean	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
Â¢	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
HA-Akt/PKB	NULL
and	NULL
20	NULL
ug	NULL
of	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
the	NULL
plasmid	NULL
encoding	NULL
N17Ras	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
harvested	NULL
the	NULL
next	NULL
day	NULL
and	NULL
stimulated	NULL
as	NULL
indicated	NULL
.	NULL

Right	NULL
panels	NULL
labeled	NULL
H2B	NULL
show	NULL
autoradiographs	NULL
of	NULL
PKB	NULL
activity	NULL
isolated	NULL
from	NULL
control	NULL
cells	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
or	NULL
cells	NULL
expressing	NULL
the	NULL
dominant	NULL
inhibitory	NULL
Ras	NULL
mutant	NULL
N17ras	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
.	NULL

Left	NULL
labeled	NULL
panels	NULL
,	NULL
labeled	NULL
WB	NULL
,	NULL
show	NULL
Ras	NULL
Western	NULL
blots	NULL
of	NULL
control	NULL
cells	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
or	NULL
cells	NULL
expressing	NULL
N17Ras	NULL
(	NULL
bottom	NULL
panel	NULL
.	NULL

Akt/PKB	NULL
activity	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
in	NULL
a	NULL
vivo	NULL
(	NULL
Reif	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Membrane-localised	NULL
rCD2p110	NULL
or	NULL
constitutively	NULL
active	NULL
Ras	NULL
,	NULL
v-Ha-ras	NULL
,	NULL
were	NULL
co-expressed	NULL
with	NULL
HA-epitope	NULL
tagged	NULL
PKB	NULL
and	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
tagged	NULL
enzyme	NULL
was	NULL
assessed	NULL
in	NULL
immune	NULL
complex	NULL
kinase	NULL
assays	NULL
using	NULL
histone	NULL
2B	NULL
(	NULL
H2B	NULL
)	NULL
as	NULL
a	NULL
substrate	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
1	NULL
demonstrate	NULL
that	NULL
co-expression	NULL
of	NULL
the	NULL
membrane-localised	NULL
rCD2p110	NULL
induced	NULL
a	NULL
robust	NULL
activation	NULL
of	NULL
Akt/PKB	NULL
.	NULL

This	NULL
stimulatory	NULL
effect	NULL
of	NULL
rCD2p110	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
kinase	NULL
activity	NULL
of	NULL
the	NULL
chimera	NULL
since	NULL
co-expression	NULL
of	NULL
kinase	NULL
inactive	NULL
rCD2p110-R/P	NULL
did	NULL
not	NULL
stimulate	NULL
Akt/	NULL
PKB	NULL
activity	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
expression	NULL
of	NULL
constitutively	NULL
active	NULL
v-Ha-Ras	NULL
was	NULL
consistently	NULL
unable	NULL
to	NULL
stimulate	NULL
the	NULL
activity	NULL
of	NULL
Akt/PKB	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
v-Ha-ras	NULL
in	NULL
these	NULL
experiments	NULL
was	NULL
confirmed	NULL
by	NULL
Western	NULL
blot	NULL
analyses	NULL
.	NULL

Increasing	NULL
or	NULL
decreasing	NULL
v-Ha-ras	NULL
expression	NULL
did	NULL
not	NULL
induce	NULL
Akt/PKB	NULL
kinase	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
parallel	NULL
experiments	NULL
,	NULL
verification	NULL
of	NULL
p2l1ras	NULL
functional	NULL
activity	NULL
was	NULL
obtained	NULL
by	NULL
monitoring	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
downstream	NULL
target	NULL
for	NULL
Ras	NULL
action	NULL
,	NULL
the	NULL
MAP	NULL
kinase	NULL
Erk2	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transiently	NULL
co-transfected	NULL
with	NULL
the	NULL
expression	NULL
vector	NULL
encoding	NULL
activated	NULL
p2lras	NULL
and	NULL
a	NULL
myc-epitope	NULL
tagged	NULL
p42	NULL
Erk2	NULL
.	NULL

The	NULL
kinase	NULL
activity	NULL
of	NULL
Erk2	NULL
was	NULL
then	NULL
assessed	NULL
by	NULL
standard	NULL
protocols	NULL
and	NULL
expression	NULL
of	NULL
myc-tagged	NULL
Erk2	NULL
was	NULL
confirmed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
1b	NULL
show	NULL
that	NULL
expression	NULL
of	NULL
v-Ha-ras	NULL
could	NULL
potently	NULL
stimulate	NULL
Erk2	NULL
kinase	NULL
activity	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

T	NULL
cells	NULL
express	NULL
all	NULL
three	NULL
Ras	NULL
proteins	NULL
,	NULL
Ha	NULL
Ras	NULL
,	NULL
K-Ras	NULL
and	NULL
N-Ras	NULL
and	NULL
we	NULL
were	NULL
interested	NULL
to	NULL
determine	NULL
whether	NULL
activation	NULL
of	NULL
the	NULL
normal	NULL
spectrum	NULL
of	NULL
endogenous	NULL
Ras	NULL
proteins	NULL
in	NULL
T	NULL
cells	NULL
was	NULL
able	NULL
to	NULL
stimulate	NULL
PKB	NULL
activity	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
it	NULL
is	NULL
well	NULL
established	NULL
that	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
with	NULL
phorbol	NULL
esters	NULL
is	NULL
a	NULL
powerful	NULL
stimulus	NULL
for	NULL
inducing	NULL
the	NULL
accumulation	NULL
of	NULL
active	NULL
Ras-GTP	NULL
complexes	NULL
.	NULL

Moreover	NULL
,	NULL
phorbol	NULL
esters	NULL
induce	NULL
activation	NULL
of	NULL
N	NULL
ras	NULL
,	NULL
Ha	NULL
Ras	NULL
and	NULL
Ki	NULL
Ras	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
initiate	NULL
activation	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
Erk2	NULL
by	NULL
p2lras	NULL
dependent	NULL
signaling	NULL
pathways	NULL
(	NULL
Downward	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
1c	NULL
show	NULL
that	NULL
phorbol	NULL
12,13	NULL
dibutyrate	NULL
(	NULL
Pdbu	NULL
)	NULL
is	NULL
unable	NULL
to	NULL
activate	NULL
PKB	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
also	NULL
seen	NULL
that	NULL
activation	NULL
of	NULL
Ras	NULL
with	NULL
phorbol	NULL
esters	NULL
fails	NULL
to	NULL
stimulate	NULL
PKB	NULL
in	NULL
peripheral	NULL
blood	NULL
derived	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Also	NULL
in	NULL
the	NULL
IL-2	NULL
dependent	NULL
T	NULL
cell	NULL
line	NULL
Kit225	NULL
phorbol	NULL
esters	NULL
failed	NULL
to	NULL
stimulate	NULL
PKB	NULL
activity	NULL
although	NULL
they	NULL
effectively	NULL
activate	NULL
p2lras	NULL
(	NULL
Reif	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
main	NULL
physiological	NULL
stimlus	NULL
for	NULL
Ras	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
(	NULL
Downward	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
lc	NULL
show	NULL
that	NULL
triggering	NULL
of	NULL
the	NULL
TCR	NULL
induces	NULL
a	NULL
rapid	NULL
activation	NULL
of	NULL
PKB	NULL
.	NULL

The	NULL
TCR/	NULL
PKB	NULL
response	NULL
is	NULL
prevented	NULL
by	NULL
the	NULL
PtdIns	NULL
3-kinase	NULL
inhibitor	NULL
LY294002	NULL
.	NULL

However	NULL
,	NULL
expression	NULL
of	NULL
N17	NULL
Ras	NULL
,	NULL
a	NULL
dominant	NULL
inhibitory	NULL
Ras	NULL
mutant	NULL
,	NULL
does	NULL
not	NULL
prevent	NULL
TCR	NULL
stimulation	NULL
of	NULL
Akt/PKB	NULL
(	NULL
Figure	NULL
1Â¢c	NULL
)	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
results	NULL
show	NULL
that	NULL
p21ras	NULL
signals	NULL
are	NULL
not	NULL
sufficient	NULL
or	NULL
required	NULL
for	NULL
PKB	NULL
stimulation	NULL
in	NULL
a	NULL
number	NULL
of	NULL
different	NULL
T	NULL
cell	NULL
populations	NULL
.	NULL

PtdIns	NULL
3-kinase	NULL
does	NULL
not	NULL
couple	NULL
p2Iras	NULL
to	NULL
the	NULL
Rac	NULL
mediated	NULL
signals	NULL
that	NULL
transcriptionally	NULL
activate	NULL
API	NULL
Expression	NULL
of	NULL
constitutively	NULL
active	NULL
PtdIns	NULL
3-kinase	NULL
can	NULL
bypass	NULL
p2lras	NULL
and	NULL
induce	NULL
the	NULL
Rac	NULL
mediated	NULL
signals	NULL
required	NULL
for	NULL
cell	NULL
transformation	NULL
(	NULL
Rodriguez-Viciana	NULL
et	NULL
Ras	NULL
effector	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
E	NULL
Genot	NULL
et	NULL
al	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Antigen	NULL
receptor	NULL
activation	NULL
of	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
API	NULL
or	NULL
NFAT	NULL
is	NULL
essential	NULL
for	NULL
cytokine	NULL
gene	NULL
induction	NULL
in	NULL
lymphocytes	NULL
.	NULL

A	NULL
critical	NULL
signaling	NULL
pathway	NULL
involved	NULL
in	NULL
this	NULL
response	NULL
is	NULL
initated	NULL
by	NULL
p21ras	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
API	NULL
complexes	NULL
in	NULL
T	NULL
cells	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
Ras	NULL
;	NULL
this	NULL
Ras	NULL
response	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
function	NULL
of	NULL
Rac-l	NULL
and	NULL
can	NULL
be	NULL
mimicked	NULL
by	NULL
expression	NULL
of	NULL
constitutively	NULL
active	NULL
Rac-1	NULL
.	NULL

The	NULL
experiments	NULL
in	NULL
Figure	NULL
2a	NULL
show	NULL
that	NULL
expression	NULL
of	NULL
a	NULL
constitutively	NULL
active	NULL
Ras	NULL
mutant	NULL
,	NULL
v-Ha-ras	NULL
stimulates	NULL
AP-1	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Ras	NULL
induction	NULL
of	NULL
API	NULL
is	NULL
blocked	NULL
by	NULL
expression	NULL
of	NULL
a	NULL
dominant	NULL
inhibitory	NULL
mutant	NULL
of	NULL
Rac	NULL
,	NULL
Nl7Rac	NULL
(	NULL
Genot	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
constitutively	NULL
active	NULL
Rac	NULL
,	NULL
V12Rac	NULL
could	NULL
also	NULL
potently	NULL
stimulate	NULL
AP1-controlled	NULL
gene	NULL
transcription	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
Figure	NULL
2a	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
Ras	NULL
regulation	NULL
of	NULL
AP-1	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
Rac	NULL
GTPase	NULL
.	NULL

To	NULL
investigate	NULL
directly	NULL
whether	NULL
PtdIns	NULL
3-kinase	NULL
signals	NULL
are	NULL
sufficient	NULL
to	NULL
activate	NULL
the	NULL
Rac-1/AP-1	NULL
response	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
constitutively	NULL
active	NULL
PtdIns	NULL
3-kinase	NULL
,	NULL
rCD2p110	NULL
,	NULL
on	NULL
API	NULL
transcriptional	NULL
activity	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
2a	NULL
show	NULL
that	NULL
expression	NULL
of	NULL
active	NULL
PtdIns	NULL
3-kinase	NULL
was	NULL
not	NULL
able	NULL
to	NULL
mimic	NULL
p21lras	NULL
or	NULL
Rac-1	NULL
signals	NULL
and	NULL
induce	NULL
API	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
second	NULL
strategy	NULL
to	NULL
explore	NULL
the	NULL
role	NULL
of	NULL
PtdIns	NULL
3-kinase	NULL
in	NULL
Ras/AP-1	NULL
responses	NULL
involved	NULL
the	NULL
use	NULL
of	NULL
the	NULL
inhibitor	NULL
LY294002	NULL
,	NULL
a	NULL
well	NULL
characterised	NULL
PtdIns	NULL
3-kinase	NULL
inhibitor	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
ATP	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
p110	NULL
catalytic	NULL
subunit	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
2b	NULL
show	NULL
that	NULL
LY294002	NULL
had	NULL
no	NULL
effect	NULL
AP-1	NULL
activation	NULL
initiated	NULL
by	NULL
expression	NULL
of	NULL
activated	NULL
p2lras	NULL
.	NULL

We	NULL
also	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
LY294002	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
endogenous	NULL
Ras	NULL
molecules	NULL
to	NULL
transcriptionally	NULL
activate	NULL
AP-1	NULL
.	NULL

TCR	NULL
agonists	NULL
or	NULL
phorbol	NULL
esters	NULL
initiate	NULL
the	NULL
Ras/Rac	NULL
dependent	NULL
pathways	NULL
that	NULL
regulate	NULL
AP-1	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
2Â¢	NULL
show	NULL
that	NULL
neither	NULL
TCR	NULL
or	NULL
phorbol	NULL
ester	NULL
induction	NULL
of	NULL
AP-1	NULL
is	NULL
blocked	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
LY294002	NULL
.	NULL

The	NULL
drug	NULL
dose	NULL
(	NULL
10	NULL
uM	NULL
)	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
is	NULL
effective	NULL
at	NULL
inhibiting	NULL
endogenous	NULL
PItdIns	NULL
3-kinase	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
as	NULL
judged	NULL
by	NULL
direct	NULL
measurements	NULL
of	NULL
PtdIns	NULL
3-kinase	NULL
enzymatic	NULL
activity	NULL
from	NULL
T	NULL
cells	NULL
treated	NULL
with	NULL
the	NULL
compound	NULL
(	NULL
Reif	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
effectiveness	NULL
of	NULL
LY294002	NULL
as	NULL
a	NULL
supressor	NULL
of	NULL
endogenous	NULL
PtdIns	NULL
3-kinase	NULL
mediated	NULL
responses	NULL
was	NULL
simultaneously	NULL
judged	NULL
in	NULL
terms	NULL
of	NULL
its	NULL
ability	NULL
to	NULL
prevent	NULL
activation	NULL
of	NULL
Akt/PKB	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
2d	NULL
show	NULL
that	NULL
triggering	NULL
of	NULL
the	NULL
TCR	NULL
activates	NULL
Akt/PKB	NULL
as	NULL
does	NULL
expression	NULL
of	NULL
the	NULL
constitutively	NULL
active	NULL
PtdIns	NULL
3-kinase	NULL
rCD2p110	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
both	NULL
agonists	NULL
to	NULL
stimulate	NULL
PKB	NULL
is	NULL
prevented	NULL
by	NULL
treatment	NULL
of	NULL
the	NULL
T	NULL
cells	NULL
with	NULL
LY294002	NULL
.	NULL

These	NULL
results	NULL
confirm	NULL
that	NULL
both	NULL
the	NULL
TCR	NULL
and	NULL
mutationally	NULL
activated	NULL
p2lras	NULL
can	NULL
initiate	NULL
a	NULL
Rac	NULL
mediated	NULL
signaling	NULL
pathways	NULL
that	NULL
transcriptionally	NULL
activates	NULL
AP-1	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PtdIns	NULL
3-kinase	NULL
signaling	NULL
pathways	NULL
.	NULL

p2lras	NULL
but	NULL
not	NULL
PtdIns	NULL
3-kinase	NULL
signals	NULL
are	NULL
able	NULL
to	NULL
regulate	NULL
Ink	NULL
The	NULL
GTPase	NULL
Rac	NULL
can	NULL
stimulate	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
Jnk/	NULL
Sapk	NULL
pathway	NULL
in	NULL
T	NULL
cells	NULL
:	NULL
expression	NULL
of	NULL
constitutively	NULL
active	NULL
Rac-1	NULL
results	NULL
in	NULL
activation	NULL
of	NULL
Jnk/Sapk	NULL
and	NULL
expression	NULL
of	NULL
dominant	NULL
inhibitory	NULL
mutants	NULL
of	NULL
Rac-1	NULL
prevents	NULL
Jnk/Sapk	NULL
activation	NULL
during	NULL
T	NULL
cell	NULL
activation	NULL
(	NULL
Jacinto	NULL
,	NULL
1998	NULL
)	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
ability	NULL
of	NULL
PtdIns	NULL
3	NULL
1733	NULL
Ras	NULL
effector	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
E	NULL
Genot	NULL
et	NULL
al	NULL
1734	NULL
kinase	NULL
signals	NULL
to	NULL
stimulate	NULL
the	NULL
activity	NULL
of	NULL
Jnk/Sapk	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
effect	NULL
of	NULL
a	NULL
constitutively	NULL
active	NULL
mutant	NULL
of	NULL
PtdIns	NULL
3-kinase	NULL
on	NULL
Jnk	NULL
regulation	NULL
,	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
HA-epitope	NULL
tagged	NULL
Jnk2	NULL
(	NULL
p54	NULL
$	NULL
B	NULL
Sapk	NULL
)	NULL
and	NULL
rCD2p1l10	NULL
,	NULL
v-Ha-ras	NULL
,	NULL
V1l2Rac	NULL
,	NULL
or	NULL
the	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
protein	NULL
Dbl	NULL
.	NULL

Co-expression	NULL
of	NULL
V12Rac	NULL
stimulated	NULL
Junk	NULL
activity	NULL
20-fold	NULL
respectively	NULL
,	NULL
as	NULL
did	NULL
activation	NULL
of	NULL
endogenous	NULL
Rac	NULL
signaling	NULL
pathways	NULL
by	NULL
expression	NULL
of	NULL
the	NULL
Dbl	NULL
oncogene	NULL
,	NULL
an	NULL
activated	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
protein	NULL
that	NULL
triggers	NULL
endogenous	NULL
Rac	NULL
responses	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
an	NULL
activated	NULL
p21lras	NULL
oncogene	NULL
,	NULL
v-Ha-ras	NULL
,	NULL
also	NULL
generates	NULL
signals	NULL
that	NULL
are	NULL
sufficient	NULL
to	NULL
activate	NULL
the	NULL
Rac/Jnk	NULL
pathway	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
expression	NULL
of	NULL
mutationally	NULL
activated	NULL
Ras	NULL
potentiates	NULL
the	NULL
Jnk	NULL
responses	NULL
triggered	NULL
by	NULL
calcium	NULL
ionophore	NULL
and	NULL
phorbol	NULL
ester	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figure	NULL
3	NULL
also	NULL
show	NULL
the	NULL
effect	NULL
of	NULL
PtdIns	NULL
3-Kinase	NULL
on	NULL
the	NULL
Jnk	NULL
responses	NULL
in	NULL
T	NULL
cells	NULL
;	NULL
expression	NULL
of	NULL
rCD2p110	NULL
did	NULL
not	NULL
result	NULL
in	NULL
Jnk	NULL
activation	NULL
nor	NULL
did	NULL
PtdIns	NULL
3-kinase	NULL
signals	NULL
co-operate	NULL
with	NULL
phorbol	NULL
esters	NULL
and	NULL
calcium	NULL
signals	NULL
to	NULL
stimulate	NULL
Jnk	NULL
activity	NULL
.	NULL

Further	NULL
confirmation	NULL
that	NULL
PtdIns	NULL
3-Kinase	NULL
does	NULL
not	NULL
mediate	NULL
the	NULL
effects	NULL
of	NULL
activated	NULL
Ras	NULL
on	NULL
the	NULL
Jnk	NULL
pathway	NULL
came	NULL
from	NULL
experiments	NULL
that	NULL
explored	NULL
the	NULL
effect	NULL
of	NULL
LY294002	NULL
on	NULL
Jnk	NULL
activation	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
it	NULL
was	NULL
noted	NULL
that	NULL
inhibition	NULL
of	NULL
PtdIns	NULL
3-kinase	NULL
with	NULL
the	NULL
LY294002	NULL
compound	NULL
raised	NULL
basal	NULL
levels	NULL
of	NULL
Jnk	NULL
activity	NULL
but	NULL
did	NULL
not	NULL
suppress	NULL
the	NULL
Jnk	NULL
response	NULL
induced	NULL
by	NULL
activated	NULL
p21lras	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

Discussion	NULL
p2lras	NULL
is	NULL
an	NULL
important	NULL
regulatory	NULL
molecule	NULL
that	NULL
has	NULL
critical	NULL
functions	NULL
in	NULL
thymocytes	NULL
and	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
.	NULL

One	NULL
object	NULL
of	NULL
the	NULL
present	NULL
study	NULL
was	NULL
to	NULL
a_	NULL
80	NULL
10	NULL
232	NULL
5	NULL
|A	NULL
B	NULL
&	NULL
3	NULL
|	NULL
ul	NULL
g	NULL
Â§	NULL
2	NULL
60-	NULL
2	NULL
=	NULL
6	NULL
2	NULL
Â°	NULL
&	NULL
c	NULL
0	NULL
S	NULL
Z	NULL
40â	NULL
a	NULL
>	NULL
-o	NULL
4	NULL
Cs	NULL
0	NULL
0	NULL
8	NULL
20	NULL
E-E-	NULL
-	NULL
2	NULL
<	NULL
L	NULL
<	NULL
.	NULL

Q	NULL
&	NULL
a	NULL
-	NULL
0	NULL
T	NULL
``	NULL
-T-	NULL
T	NULL
-	NULL
0	NULL
A	NULL
<	NULL
o	NULL
o	NULL
g	NULL
>	NULL
-	NULL
B0	NULL
-	NULL
b0	NULL
-	NULL
poo	NULL
B0	NULL
_	NULL
P0	NULL
<	NULL
.	NULL

Tie	NULL
2	NULL
a	NULL
o	NULL
Â§	NULL
a_	NULL
o	NULL
2	NULL
-	NULL
aAa	NULL
9Â°	NULL
500g	NULL
7	NULL
80	NULL
g	NULL
7	NULL
>	NULL
-	NULL
A-	NULL
Z	NULL
fo	NULL
$	NULL
fo	NULL
3	NULL
2	NULL
&	NULL
So	NULL
3	NULL
$	NULL
o	NULL
3	NULL
A	NULL
>	NULL
-	NULL
T	NULL
>	NULL
-	NULL
CFH	NULL
UQ	NULL
-	NULL
>	NULL
-	NULL
Â»	NULL
a	NULL
control	NULL
Ly	NULL
294002	NULL
%	NULL
of	NULL
the	NULL
control	NULL
response	NULL
``	NULL
PEG	NULL
ge	NULL
50-7	NULL
_	NULL
C	NULL
--	NULL
-	NULL
_	NULL
UCHTI	NULL
O	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
LY294002	NULL
(	NULL
uM	NULL
)	NULL
explore	NULL
whether	NULL
the	NULL
serine/threonine	NULL
kinase	NULL
Akt/PKB	NULL
is	NULL
a	NULL
downstream	NULL
effector	NULL
of	NULL
p2lras	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
impetus	NULL
for	NULL
these	NULL
questions	NULL
comes	NULL
from	NULL
knowledge	NULL
that	NULL
p21ras	NULL
function	NULL
is	NULL
critical	NULL
for	NULL
T	NULL
cell	NULL
activation	NULL
yet	NULL
little	NULL
is	NULL
known	NULL
about	NULL
Ras	NULL
signaling	NULL
pathways	NULL
in	NULL
lymphocytes	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
PtdIns	NULL
3-kinase	NULL
couples	NULL
Ras	NULL
to	NULL
Akt/PKB	NULL
in	NULL
fibroblasts	NULL
and	NULL
epithelial	NULL
cells	NULL
(	NULL
Kauffmann-Zeh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Marte	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Rodriguez-Viciana	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
present	NULL
data	NULL
show	NULL
that	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
PtdIns	NULL
3-kinase	NULL
can	NULL
stimulate	NULL
Akt/PKB	NULL
but	NULL
expression	NULL
of	NULL
a	NULL
mutationally	NULL
activated	NULL
Ras	NULL
,	NULL
v-Ha-ras	NULL
does	NULL
not	NULL
initiate	NULL
this	NULL
response	NULL
.	NULL

More	NULL
Ras	NULL
effector	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
E	NULL
Genot	NULL
et	NULL
al	NULL
over	NULL
,	NULL
activation	NULL
of	NULL
endogenous	NULL
Ras	NULL
proteins	NULL
in	NULL
T	NULL
cells	NULL
with	NULL
phorbol	NULL
esters	NULL
does	NULL
not	NULL
result	NULL
in	NULL
PKB	NULL
activation	NULL
.	NULL

The	NULL
present	NULL
data	NULL
also	NULL
show	NULL
that	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
via	NULL
the	NULL
TCR	NULL
activates	NULL
PKB/Akt	NULL
.	NULL

This	NULL
response	NULL
requires	NULL
activation	NULL
of	NULL
PtdIns	NULL
3-kinase	NULL
but	NULL
not	NULL
p2lras	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
Ras	NULL
signals	NULL
are	NULL
not	NULL
sufficient	NULL
nor	NULL
are	NULL
they	NULL
obligate	NULL
for	NULL
Akt/PKB	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

PtdIns	NULL
3-kinase	NULL
activation	NULL
of	NULL
Akt/PKB	NULL
thus	NULL
seems	NULL
to	NULL
be	NULL
a	NULL
ubiquitous	NULL
response	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
role	NULL
of	NULL
p21ras	NULL
in	NULL
Akt/PKB	NULL
regulation	NULL
may	NULL
be	NULL
restricted	NULL
to	NULL
certain	NULL
cell	NULL
lineages	NULL
or	NULL
differentiation	NULL
stages	NULL
of	NULL
a	NULL
cell	NULL
type	NULL
.	NULL

*	NULL
~~~	NULL
D	NULL
Akt/PKB	NULL
H2B	NULL
g	NULL
6	NULL
5â	NULL
s	NULL
4-â¬	NULL
5	NULL
``	NULL
C	NULL
â¬	NULL
2	NULL
lâ	NULL
O-LY294002	NULL
+	NULL
~	NULL
w	NULL
)	NULL
C.	NULL
2	NULL
UO	NULL
empty	NULL
I+|+I+	NULL
3	NULL
p	NULL
S	NULL
9	NULL
&	NULL
&	NULL
QQ	NULL
,	NULL
__Q4Q4	NULL
EEQQOA	NULL
9	NULL
Â°	NULL
19	NULL
%	NULL
alo	NULL
ao	NULL
7Â°	NULL
<	NULL
2	NULL
8	NULL
z	NULL
z	NULL
UCHTI	NULL
-	NULL
Z	NULL
Z	NULL
a_	NULL
a	NULL
o	NULL
Â©	NULL
Figure	NULL
2	NULL
-	NULL
(	NULL
a	NULL
)	NULL
10	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
the	NULL
AP1	NULL
CAT	NULL
reporter	NULL
construct	NULL
and	NULL
10	NULL
ug	NULL
of	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
the	NULL
plasmid	NULL
encoding	NULL
v-Ha-ras	NULL
,	NULL
V12Rac	NULL
,	NULL
rCD2p110	NULL
or	NULL
rCD2p110	NULL
R/P	NULL
.	NULL

At	NULL
18	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
transfected	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
extracts	NULL
were	NULL
made	NULL
and	NULL
CAT	NULL
reporter	NULL
activity	NULL
was	NULL
assessed	NULL
.	NULL

Data	NULL
of	NULL
one	NULL
representative	NULL
experiment	NULL
out	NULL
of	NULL
five	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
CAT	NULL
activity	NULL
is	NULL
presented	NULL
as	NULL
percentage	NULL
conversion	NULL
of	NULL
substrate	NULL
into	NULL
product	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
the	NULL
API	NULL
CAT	NULL
reporter	NULL
construct	NULL
2	NULL
or	NULL
10	NULL
ug	NULL
of	NULL
the	NULL
v-Ha-ras	NULL
.	NULL

Each	NULL
sample	NULL
was	NULL
split	NULL
in	NULL
two	NULL
and	NULL
either	NULL
10	NULL
um	NULL
of	NULL
LY294002	NULL
inhibitor	NULL
or	NULL
vehicle	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
right	NULL
after	NULL
the	NULL
transfection	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
and	NULL
CAT	NULL
reporter	NULL
activity	NULL
was	NULL
assessed	NULL
18	NULL
h	NULL
post	NULL
transfection	NULL
.	NULL

The	NULL
CAT	NULL
activity	NULL
is	NULL
presented	NULL
as	NULL
percentage	NULL
conversion	NULL
of	NULL
substrate	NULL
into	NULL
product	NULL
.	NULL

Mean	NULL
of	NULL
duplicate	NULL
samples	NULL
are	NULL
shown	NULL
.	NULL

One	NULL
representative	NULL
experiment	NULL
out	NULL
of	NULL
three	NULL
.	NULL

(	NULL
Â¢	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-tranfected	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
the	NULL
AP-1CAT	NULL
reporter	NULL
gene	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
pre-treated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
the	NULL
LY294002	NULL
inhibitor	NULL
.	NULL

Stimuli	NULL
were	NULL
then	NULL
applied	NULL
as	NULL
indicated	NULL
,	NULL
for	NULL
18	NULL
h.	NULL
Cells	NULL
were	NULL
then	NULL
harvested	NULL
and	NULL
CAT	NULL
activity	NULL
assessed	NULL
.	NULL

Results	NULL
are	NULL
presented	NULL
as	NULL
percentage	NULL
of	NULL
the	NULL
maximal	NULL
response	NULL
obtained	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
vehicle	NULL
DMSO	NULL
only	NULL
.	NULL

(	NULL
d	NULL
)	NULL
Cells	NULL
were	NULL
co-transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
Akt/PKB	NULL
plasmid	NULL
together	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
the	NULL
plasmid	NULL
encoding	NULL
constitutively	NULL
active	NULL
PtdIns	NULL
3-kinase	NULL
,	NULL
rCD2p110	NULL
or	NULL
the	NULL
kinase	NULL
dead	NULL
version	NULL
rCD2p110	NULL
R/P	NULL
.	NULL

Each	NULL
sample	NULL
was	NULL
split	NULL
in	NULL
two	NULL
,	NULL
one	NULL
was	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
um	NULL
LY294002	NULL
inhibitor	NULL
(	NULL
+	NULL
)	NULL
while	NULL
the	NULL
other	NULL
one	NULL
was	NULL
pre-treated	NULL
with	NULL
the	NULL
vehicle	NULL
DMSO	NULL
only	NULL
(	NULL
-	NULL
)	NULL
.	NULL

Eighteen	NULL
hours	NULL
later	NULL
,	NULL
samples	NULL
were	NULL
harvested	NULL
and	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
were	NULL
left	NULL
untreated	NULL
or	NULL
stimulated	NULL
for	NULL
5	NULL
min	NULL
with	NULL
UCHT1	NULL
antibodies	NULL
.	NULL

Akt/PKB	NULL
kinase	NULL
activity	NULL
was	NULL
assessed	NULL
as	NULL
described	NULL
in	NULL
Figure	NULL
la	NULL
and	NULL
is	NULL
presented	NULL
as	NULL
fold	NULL
induction	NULL
of	NULL
the	NULL
control	NULL
response	NULL
.	NULL

In	NULL
the	NULL
medium	NULL
panel	NULL
,	NULL
gel	NULL
labeled	NULL
H2B	NULL
is	NULL
an	NULL
autoradiography	NULL
of	NULL
the	NULL
H2B	NULL
substrate	NULL
after	NULL
immune	NULL
complex	NULL
assay	NULL
of	NULL
Akt/PKB	NULL
activity	NULL
.	NULL

In	NULL
the	NULL
top	NULL
panel	NULL
is	NULL
shown	NULL
the	NULL
Western	NULL
blot	NULL
of	NULL
the	NULL
Akt/PKB	NULL
proteins	NULL
present	NULL
in	NULL
the	NULL
anti-HA-tag	NULL
immunne	NULL
complex	NULL
kinase	NULL
assay	NULL
detected	NULL
with	NULL
the	NULL
Akt/PKB	NULL
polyclonal	NULL
antibodies	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
two	NULL
more	NULL
experiments	NULL
1735	NULL
Ras	NULL
effector	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
E	NULL
Genot	NULL
et	NULL
al	NULL
1736	NULL
One	NULL
common	NULL
feature	NULL
of	NULL
both	NULL
fibroblasts	NULL
and	NULL
lymphocytes	NULL
is	NULL
that	NULL
the	NULL
Rho	NULL
family	NULL
GTPase	NULL
Rac-l	NULL
has	NULL
critical	NULL
functions	NULL
in	NULL
the	NULL
biological	NULL
role	NULL
of	NULL
Ras	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
a	NULL
Ras/Rac	NULL
mediated	NULL
effector	NULL
pathway	NULL
is	NULL
important	NULL
for	NULL
antigen	NULL
receptor	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
AP-1	NULL
and	NULL
NFAT	NULL
in	NULL
lymphocytes	NULL
.	NULL

This	NULL
response	NULL
has	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cytokine	NULL
gene	NULL
induction	NULL
in	NULL
lymphocytes	NULL
(	NULL
Genot	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Turner	NULL
and	NULL
Cantrell	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

In	NULL
fibroblasts	NULL
,	NULL
PtdIns	NULL
3-kinase	NULL
signals	NULL
are	NULL
sufficient	NULL
to	NULL
ao	NULL
a	NULL
$	NULL
8	NULL
s	NULL
;	NULL
``	NULL
empty	NULL
wits	NULL
.	NULL

Jun	NULL
amo	NULL
amp	NULL
am	NULL
Â»	NULL
asm	NULL
-	NULL
tag-	NULL
]	NULL
n	NULL
}	NULL
<	NULL
2	NULL
rCD2p110	NULL
WD	NULL
_	NULL
Jun	NULL
ep	NULL
ams	NULL
amp	NULL
amp	NULL
-	NULL
tag-	NULL
}	NULL
Nk2	NULL
Ha-v-ras	NULL
so	NULL
wR	NULL
:	NULL
-e	NULL
Â»	NULL
a	NULL
Â»	NULL
csm	NULL
Â»	NULL
Â«	NULL
#	NULL
Â»	NULL
-	NULL
tag-Jnk2	NULL
V12Rac	NULL
CÂ©eo00	NULL
--	NULL
emo	NULL
amp	NULL
ane	NULL
asm	NULL
Â»	NULL
=	NULL
tag-	NULL
)	NULL
nk2	NULL
Dbi	NULL
ound	NULL
:	NULL
-	NULL
:	NULL
am	NULL
Â»	NULL
ame	NULL
asp	NULL
#	NULL
s	NULL
Â»	NULL
-	NULL
tag-	NULL
)	NULL
nk2	NULL
Figure	NULL
3	NULL
-	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
the	NULL
HA-tagged	NULL
Jnk2	NULL
and	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
with	NULL
plasmids	NULL
encoding	NULL
for	NULL
rCD2p110	NULL
,	NULL
v-Ha-ras	NULL
,	NULL
V12Rac	NULL
,	NULL
or	NULL
oncogenic	NULL
Dbl	NULL
as	NULL
indicated	NULL
.	NULL

Jnk	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

Gels	NULL
labeled	NULL
Jun	NULL
are	NULL
autoradiographies	NULL
of	NULL
the	NULL
GST-Jun	NULL
substrate	NULL
after	NULL
immune	NULL
complex	NULL
assay	NULL
of	NULL
Jnk	NULL
phosphotransferase	NULL
activities	NULL
.	NULL

Blots	NULL
labeled	NULL
tag-Jnk	NULL
2	NULL
show	NULL
the	NULL
immuno	NULL
blot	NULL
analysis	NULL
performed	NULL
on	NULL
the	NULL
Jnk	NULL
proteins	NULL
present	NULL
in	NULL
the	NULL
anti-HA-tag	NULL
immune	NULL
complex	NULL
kinase	NULL
assay	NULL
using	NULL
the	NULL
anti-Jnk2	NULL
antisera	NULL
.	NULL

The	NULL
data	NULL
are	NULL
from	NULL
a	NULL
representative	NULL
experiment	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
two	NULL
more	NULL
experiments	NULL
couple	NULL
p21lras	NULL
to	NULL
Rac	NULL
signaling	NULL
pathways	NULL
important	NULL
for	NULL
cytoskeleton	NULL
organization	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
DNA	NULL
synthesis	NULL
or	NULL
fibroblast	NULL
transformation	NULL
(	NULL
Rodriguez-Viciana	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
show	NULL
herein	NULL
that	NULL
PtdIns	NULL
3-kinase	NULL
signals	NULL
are	NULL
not	NULL
required	NULL
nor	NULL
sufficient	NULL
for	NULL
the	NULL
Rac	NULL
mediated	NULL
signaling	NULL
pathways	NULL
important	NULL
for	NULL
antigen	NULL
receptor	NULL
control	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Hence	NULL
,	NULL
PtdIns	NULL
3-kinase	NULL
is	NULL
not	NULL
a	NULL
universal	NULL
activator	NULL
of	NULL
the	NULL
GTPase	NULL
Rac	NULL
and	NULL
the	NULL
mechanism	NULL
whereby	NULL
Ras	NULL
couples	NULL
to	NULL
p2lras	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
unknown	NULL
.	NULL

In	NULL
S.	NULL
Pombe	NULL
,	NULL
a	NULL
guanine	NULL
nucleotide	NULL
exchange	NULL
protein	NULL
for	NULL
a	NULL
Cdc42	NULL
homologue	NULL
(	NULL
Scd-1	NULL
)	NULL
,	NULL
is	NULL
a	NULL
direct	NULL
Ras	NULL
effector	NULL
protein	NULL
that	NULL
regulates	NULL
morphogenesis	NULL
(	NULL
Chang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

This	NULL
provides	NULL
an	NULL
example	NULL
of	NULL
type	NULL
of	NULL
biochemical	NULL
mechanism	NULL
that	NULL
could	NULL
link	NULL
Ras	NULL
to	NULL
Rac	NULL
in	NULL
lymphocytes	NULL
.	NULL

The	NULL
present	NULL
study	NULL
could	NULL
find	NULL
no	NULL
evidence	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
PtdIns	NULL
3-kinase	NULL
in	NULL
JNK	NULL
regulation	NULL
in	NULL
T	NULL
lymphocytes	NULL
although	NULL
both	NULL
Ras	NULL
and	NULL
Rac	NULL
are	NULL
able	NULL
to	NULL
regulate	NULL
this	NULL
kinase	NULL
pathway	NULL
.	NULL

This	NULL
is	NULL
similar	NULL
to	NULL
results	NULL
described	NULL
previously	NULL
in	NULL
NIH3T3	NULL
cells	NULL
where	NULL
PtdIns	NULL
3-kinase	NULL
could	NULL
not	NULL
stimulate	NULL
JNK	NULL
or	NULL
initiate	NULL
Rac	NULL
mediated	NULL
transcription	NULL
factor	NULL
responses	NULL
(	NULL
Reif	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
PtdIns	NULL
3-kinase	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
the	NULL
MAP	NULL
kinase	NULL
Jnk	NULL
in	NULL
Cos	NULL
cells	NULL
(	NULL
Klippel	NULL
et	NULL
Jnk2	NULL
c-jun	NULL
20	NULL
18	NULL
167	NULL
147	NULL
127	NULL
10	NULL
fold	NULL
induction	NULL
32	NULL
0	NULL
30	NULL
2Â°	NULL
3	NULL
E	NULL
$	NULL
o	NULL
f	NULL
:	NULL
c	NULL
o	NULL
Â°	NULL
--	NULL
GH	NULL
-v	NULL
-	NULL
T	NULL
Pa	NULL
_	NULL
Â»	NULL
control	NULL
LY	NULL
294002	NULL
Figure	NULL
4	NULL
-	NULL
Jurkat	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
the	NULL
HA-tagged	NULL
Jnk2	NULL
and	NULL
the	NULL
empty	NULL
vector	NULL
or	NULL
the	NULL
plasmid	NULL
encoding	NULL
the	NULL
for	NULL
v-Ha-ras	NULL
.	NULL

Samples	NULL
were	NULL
split	NULL
into	NULL
two	NULL
and	NULL
one	NULL
was	NULL
treated	NULL
with	NULL
10	NULL
um	NULL
LY294002	NULL
compound	NULL
and	NULL
one	NULL
was	NULL
treated	NULL
with	NULL
the	NULL
vehicle	NULL
only	NULL
.	NULL

Jnk	NULL
kinase	NULL
activity	NULL
was	NULL
assessed	NULL
as	NULL
in	NULL
Figure	NULL
3	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

These	NULL
discrepancies	NULL
reveal	NULL
that	NULL
PtdIns	NULL
3-kinase	NULL
responses	NULL
vary	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
signaling	NULL
pathways	NULL
that	NULL
couple	NULL
Ras	NULL
and	NULL
Rho	NULL
family	NULL
GTPases	NULL
can	NULL
differ	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

The	NULL
present	NULL
results	NULL
thus	NULL
show	NULL
that	NULL
current	NULL
models	NULL
for	NULL
Ras	NULL
signaling	NULL
pathways	NULL
placing	NULL
PtdIns	NULL
3-kinase	NULL
as	NULL
a	NULL
molecular	NULL
link	NULL
between	NULL
Ras	NULL
and	NULL
Rac	NULL
may	NULL
be	NULL
true	NULL
for	NULL
some	NULL
cells	NULL
but	NULL
Ras	NULL
can	NULL
initiate	NULL
Rac-1	NULL
regulated	NULL
signaling	NULL
pathways	NULL
independently	NULL
of	NULL
PtdIns	NULL
3-kinase	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Similarily	NULL
,	NULL
PKB	NULL
is	NULL
implicated	NULL
as	NULL
a	NULL
Ras	NULL
effector	NULL
important	NULL
for	NULL
cell	NULL
survival	NULL
in	NULL
some	NULL
cell	NULL
systems	NULL
but	NULL
we	NULL
now	NULL
show	NULL
that	NULL
PKB	NULL
is	NULL
not	NULL
a	NULL
universal	NULL
Ras	NULL
effector	NULL
molecule	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

Ras	NULL
effector	NULL
pathways	NULL
can	NULL
thus	NULL
be	NULL
integrated	NULL
differently	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

This	NULL
could	NULL
reflect	NULL
fundamental	NULL
differences	NULL
between	NULL
the	NULL
'wiring	NULL
'	NULL
of	NULL
Ras	NULL
effector	NULL
pathways	NULL
in	NULL
different	NULL
cell	NULL
lineages	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Reagents	NULL
,	NULL
antibodies	NULL
and	NULL
GST	NULL
fusion	NULL
proteins	NULL
Ionomycin	NULL
(	NULL
Ca*	NULL
:	NULL
+	NULL
salt	NULL
)	NULL
,	NULL
phorbol-12,13	NULL
dibutyrate	NULL
and	NULL
LY294002	NULL
were	NULL
from	NULL
Calbiochem	NULL
Corp.	NULL
(	NULL
UK	NULL
)	NULL
.	NULL

Other	NULL
reagents	NULL
were	NULL
from	NULL
Sigma	NULL
.	NULL

The	NULL
monoclonal	NULL
antibodies	NULL
12CAS	NULL
reactive	NULL
with	NULL
HA	NULL
epitope	NULL
was	NULL
affinity	NULL
purified	NULL
from	NULL
hybridoma	NULL
supernatants	NULL
by	NULL
standard	NULL
protocols	NULL
(	NULL
ICRF	NULL
Development	NULL
Unit	NULL
)	NULL
.	NULL

Antibodies	NULL
reactive	NULL
with	NULL
Jnk2	NULL
were	NULL
from	NULL
Santa-Cruz	NULL
Biotechnology	NULL
and	NULL
polyclonal	NULL
antibodies	NULL
reactive	NULL
with	NULL
Akt/PKB	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
Incorporated	NULL
.	NULL

[	NULL
``	NULL
*C	NULL
)	NULL
-Acetyl	NULL
coenzyme	NULL
A	NULL
(	NULL
at	NULL
50-60	NULL
mCi/	NULL
mmol	NULL
)	NULL
and	NULL
peroxidase	NULL
labeled	NULL
antibodies	NULL
for	NULL
Western	NULL
blotting	NULL
were	NULL
from	NULL
Amersham	NULL
International	NULL
(	NULL
Buckingham-shire	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

H2B	NULL
was	NULL
from	NULL
Boehringer	NULL
Mannheim	NULL
.	NULL

The	NULL
pGEX-GST	NULL
c-jun	NULL
(	NULL
1-79	NULL
)	NULL
fusion	NULL
protein	NULL
was	NULL
expressed	NULL
and	NULL
affinity	NULL
purified	NULL
using	NULL
glutathione-agarose	NULL
beads	NULL
.	NULL

Plasmids	NULL
and	NULL
reporter	NULL
constructs	NULL
Expression	NULL
constructs	NULL
encoding	NULL
RSV	NULL
N17Ras	NULL
,	NULL
Myc-tagged	NULL
Erk2	NULL
,	NULL
tagged	NULL
HA-p54	NULL
Jnk2	NULL
(	NULL
SAPK	NULL
$	NULL
)	NULL
,	NULL
and	NULL
HA-PKB	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
Burgering	NULL
and	NULL
Coffer	NULL
,	NULL
1995	NULL
;	NULL
Izquierdo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Yan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

AP1	NULL
CAT	NULL
and	NULL
expression	NULL
plasmids	NULL
encoding	NULL
mutants	NULL
of	NULL
p21Ras	NULL
(	NULL
pEFv-Ha-ras	NULL
)	NULL
,	NULL
mutants	NULL
of	NULL
Rac-l	NULL
(	NULL
pEFV12Rac-1	NULL
)	NULL
or	NULL
PtdIns	NULL
3-kinase	NULL
(	NULL
pEFrCD2p110	NULL
and	NULL
pEFrCD2p11OR/P	NULL
)	NULL
have	NULL
also	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
Reif	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

All	NULL
plasmids	NULL
were	NULL
purified	NULL
by	NULL
equilibrium	NULL
centrifugation	NULL
in	NULL
CsCIl/	NULL
ethidium	NULL
bromide	NULL
gradients	NULL
by	NULL
standard	NULL
procedures	NULL
.	NULL

Cell	NULL
cuture	NULL
and	NULL
transfections	NULL
JHM1	NULL
cells	NULL
,	NULL
a	NULL
subline	NULL
of	NULL
the	NULL
human	NULL
T	NULL
acute	NULL
lymphocytic	NULL
lymphoma	NULL
cell	NULL
line	NULL
Jurkat	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
References	NULL
Alberola-Ila	NULL
J	NULL
,	NULL
Hogquist	NULL
KA	NULL
,	NULL
Swan	NULL
KA	NULL
,	NULL
Bevan	NULL
MJ	NULL
and	NULL
Perlmutter	NULL
RG	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
184	NULL
,	NULL
9-18	NULL
.	NULL

Alberola-Ila	NULL
J	NULL
,	NULL
Forbush	NULL
KA	NULL
,	NULL
Seger	NULL
R	NULL
,	NULL
Krebs	NULL
EG	NULL
and	NULL
Perlmutter	NULL
RM	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
373	NULL
,	NULL
620-623	NULL
.	NULL

Burgering	NULL
BM	NULL
and	NULL
Coffer	NULL
PJ	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
376	NULL
,	NULL
599-602	NULL
.	NULL

Cantrell	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Ann	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
14	NULL
,	NULL
259-274	NULL
.	NULL

Chang	NULL
E	NULL
,	NULL
Barr	NULL
M	NULL
,	NULL
Wang	NULL
Y	NULL
,	NULL
Jung	NULL
V	NULL
,	NULL
Xu	NULL
H	NULL
and	NULL
Wigler	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
79	NULL
,	NULL
131-141	NULL
.	NULL

Crompton	NULL
T	NULL
,	NULL
Cilmour	NULL
K	NULL
,	NULL
Owen	NULL
MJ	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
86	NULL
,	NULL
243	NULL
251	NULL
.	NULL

Downward	NULL
J	NULL
,	NULL
Graves	NULL
JD	NULL
,	NULL
Warne	NULL
PH	NULL
,	NULL
Rayter	NULL
S	NULL
and	NULL
Cantrell	NULL
DA	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
346	NULL
,	NULL
719-723	NULL
.	NULL

Ras	NULL
effector	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
E	NULL
Genot	NULL
et	NULL
al	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
heat-inactivated	NULL
foetal	NULL
calf	NULL
serum	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
DNA	NULL
transfected	NULL
in	NULL
each	NULL
experiment	NULL
were	NULL
kept	NULL
constant	NULL
by	NULL
adding	NULL
empty	NULL
vector	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
via	NULL
electroporation	NULL
(	NULL
Gene	NULL
pulser	NULL
:	NULL
Bio-Rad	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
pulsed	NULL
(	NULL
1x	NULL
10	NULL
'	NULL
cells/0.5	NULL
ml	NULL
)	NULL
in	NULL
complete	NULL
medium	NULL
at	NULL
960	NULL
uF	NULL
and	NULL
310	NULL
V.	NULL
Cells	NULL
transfected	NULL
with	NULL
similar	NULL
plasmid	NULL
mixtures	NULL
were	NULL
pooled	NULL
and	NULL
re-aliquoted	NULL
before	NULL
stimulation	NULL
.	NULL

CAT	NULL
assays	NULL
and	NULL
protein	NULL
kinase	NULL
assays	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Genot	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

For	NULL
Jnk	NULL
kinase	NULL
assays	NULL
,	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
an	NULL
HA-tagged	NULL
version	NULL
of	NULL
Jnk2	NULL
together	NULL
with	NULL
various	NULL
expression	NULL
plasmids	NULL
.	NULL

Eighteen	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
the	NULL
indicated	NULL
period	NULL
of	NULL
time	NULL
or	NULL
left	NULL
untreated	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
harvested	NULL
and	NULL
equivalent	NULL
numbers	NULL
of	NULL
living	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipita-tion	NULL
using	NULL
12CAS	NULL
antibodies	NULL
for	NULL
epitope	NULL
tagged	NULL
HA-Akt	NULL
and	NULL
HA-Jnk	NULL
by	NULL
standard	NULL
protocols	NULL
.	NULL

The	NULL
kinase	NULL
reaction	NULL
was	NULL
performed	NULL
using	NULL
GST-Jun	NULL
as	NULL
a	NULL
substrate	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ATP	NULL
.	NULL

After	NULL
incubation	NULL
at	NULL
30Â°C	NULL
for	NULL
30	NULL
min	NULL
,	NULL
the	NULL
reaction	NULL
was	NULL
stopped	NULL
with	NULL
Laemmli	NULL
sample	NULL
buffer	NULL
and	NULL
kinase	NULL
reaction	NULL
products	NULL
were	NULL
analysed	NULL
on	NULL
a	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
.	NULL

The	NULL
lower	NULL
half	NULL
of	NULL
the	NULL
gel	NULL
was	NULL
dried	NULL
down	NULL
and	NULL
[	NULL
P	NULL
]	NULL
incorporation	NULL
into	NULL
c-jun	NULL
was	NULL
quantitated	NULL
using	NULL
a	NULL
phosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

The	NULL
upper	NULL
part	NULL
of	NULL
the	NULL
gel	NULL
containing	NULL
immunoprecipitated	NULL
tagged	NULL
protein	NULL
kinase	NULL
was	NULL
transfered	NULL
onto	NULL
polyvinyldifluoridine	NULL
membranes	NULL
(	NULL
Immobilon	NULL
,	NULL
Millipore	NULL
)	NULL
and	NULL
detected	NULL
with	NULL
anti-Jnk2	NULL
antibodies	NULL
,	NULL
ECL	NULL
Western	NULL
blotting	NULL
detection	NULL
reagents	NULL
(	NULL
Amersham	NULL
)	NULL
followed	NULL
by	NULL
auto	NULL
radiography	NULL
.	NULL

Kinase	NULL
assays	NULL
for	NULL
Akt/PKB	NULL
were	NULL
performed	NULL
similarly	NULL
,	NULL
using	NULL
H2B	NULL
as	NULL
a	NULL
substrate	NULL
and	NULL
anti-PKB	NULL
antibodies	NULL
for	NULL
kinase	NULL
detection	NULL
.	NULL

Erk2	NULL
kinase	NULL
assays	NULL
were	NULL
performed	NULL
by	NULL
immunoprecipitat-ing	NULL
myc-tagged	NULL
Erk2	NULL
with	NULL
9E10	NULL
antibodies	NULL
and	NULL
with	NULL
myelin	NULL
basic	NULL
protein	NULL
as	NULL
a	NULL
substrate	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
Akt/PKB	NULL
kinase	NULL
assays	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
kinase	NULL
expressed	NULL
was	NULL
determined	NULL
by	NULL
scanning	NULL
the	NULL
autoradiography	NULL
of	NULL
the	NULL
Western	NULL
blot	NULL
and	NULL
processing	NULL
the	NULL
data	NULL
with	NULL
the	NULL
Adobe	NULL
Photoshop	NULL
program	NULL
.	NULL

H2B	NULL
phosphorylation	NULL
was	NULL
normalised	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
HA-Akt/PKB	NULL
in	NULL
each	NULL
sample	NULL
and	NULL
thus	NULL
expressed	NULL
as	NULL
fold	NULL
increase	NULL
of	NULL
the	NULL
control	NULL
response	NULL
.	NULL

Acknowledgements	NULL
KR	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
Boehringer	NULL
Ingelheim	NULL
Fellowship	NULL
.	NULL

This	NULL
work	NULL
was	NULL
funded	NULL
by	NULL
the	NULL
Imperial	NULL
Cancer	NULL
Research	NULL
Fund	NULL
.	NULL

EG	NULL
is	NULL
supported	NULL
by	NULL
a	NULL
Wellcome	NULL
Foundation	NULL
Grant	NULL
DMIH	NULL
3468	NULL
.	NULL

We	NULL
would	NULL
like	NULL
to	NULL
thank	NULL
B	NULL
Burgering	NULL
and	NULL
A	NULL
Hall	NULL
for	NULL
PKB	NULL
and	NULL
Rac	NULL
constructs	NULL
respectively	NULL
.	NULL

Genot	NULL
E	NULL
,	NULL
Cleverley	NULL
S	NULL
,	NULL
Henning	NULL
S	NULL
and	NULL
Cantrell	NULL
DA	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

EMBO	NULL
.	NULL

J.	NULL
,	NULL
151	NULL
,	NULL
3923-3933	NULL
.	NULL

Izquierdo	NULL
M	NULL
,	NULL
Bowden	NULL
S	NULL
and	NULL
Cantrell	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
180	NULL
,	NULL
401-406	NULL
.	NULL

Izquierdo	NULL
M	NULL
,	NULL
Leevers	NULL
SJ	NULL
,	NULL
Marshall	NULL
,	NULL
C	NULL
and	NULL
Cantrell	NULL
DA	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
178	NULL
,	NULL
1199-1208	NULL
.	NULL

Jacinto	NULL
E	NULL
,	NULL
Werlen	NULL
G	NULL
,	NULL
Karin	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
8	NULL
,	NULL
31-41	NULL
.	NULL

Kauffmann-Zeh	NULL
A	NULL
,	NULL
Rodriguez-Viciana	NULL
P	NULL
,	NULL
Ulrich	NULL
E	NULL
,	NULL
Gilbert	NULL
C	NULL
,	NULL
Coffer	NULL
P	NULL
,	NULL
Downward	NULL
J	NULL
and	NULL
Evan	NULL
G.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
385	NULL
,	NULL
544-548	NULL
.	NULL

1737	NULL
1738	NULL
Ras	NULL
effector	NULL
pathways	NULL
in	NULL
T	NULL
cells	NULL
E	NULL
Genot	NULL
et	NULL
al	NULL
Klippel	NULL
A	NULL
,	NULL
Reinhard	NULL
C	NULL
,	NULL
Kavanaugh	NULL
WM	NULL
,	NULL
Apell	NULL
G	NULL
,	NULL
Escobedo	NULL
MA	NULL
and	NULL
Williams	NULL
LT.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
4117-4127	NULL
.	NULL

Marte	NULL
BM	NULL
,	NULL
Rodriguez-Viciane	NULL
P	NULL
,	NULL
Wennstrom	NULL
S	NULL
,	NULL
Warne	NULL
PH	NULL
and	NULL
Downward	NULL
J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
7	NULL
,	NULL
63-70	NULL
.	NULL

Panayotou	NULL
G	NULL
and	NULL
Waterfield	NULL
MD	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Trends	NULL
Cell	NULL
Biol	NULL
.	NULL

,	NULL
2	NULL
,	NULL
358-360	NULL
.	NULL

Qiu	NULL
RG	NULL
,	NULL
Chen	NULL
J	NULL
,	NULL
Kirn	NULL
D	NULL
,	NULL
McCormick	NULL
F	NULL
and	NULL
Symons	NULL
M.	NULL
(	NULL
1995a	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
374	NULL
,	NULL
457-459	NULL
.	NULL

Qiu	NULL
RG	NULL
,	NULL
Chen	NULL
J	NULL
,	NULL
McCormick	NULL
F	NULL
and	NULL
Symons	NULL
M.	NULL
(	NULL
1995b	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
92	NULL
,	NULL
11781-11785	NULL
.	NULL

Rameh	NULL
LE	NULL
,	NULL
Arvidsson	NULL
A-K	NULL
,	NULL
Carraway	NULL
I	NULL
,	NULL
KL	NULL
,	NULL
Couvillon	NULL
AD	NULL
,	NULL
Rathbun	NULL
G	NULL
,	NULL
Crompton	NULL
A	NULL
,	NULL
VanRenterghem	NULL
B	NULL
,	NULL
Czech	NULL
MP	NULL
,	NULL
Ravichandran	NULL
KS	NULL
,	NULL
Burakoff	NULL
SJ	NULL
,	NULL
Wang	NULL
D-S	NULL
,	NULL
Chen	NULL
C-S	NULL
and	NULL
Cantley	NULL
LC	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
272	NULL
,	NULL
22059-22066	NULL
.	NULL

Reif	NULL
K	NULL
,	NULL
Burgering	NULL
BMT	NULL
and	NULL
Cantrell	NULL
DA	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

J.	NULL
Bio/	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
272	NULL
,	NULL
14426-14438	NULL
.	NULL

Reif	NULL
K	NULL
,	NULL
Nobes	NULL
CD	NULL
,	NULL
Thomas	NULL
G	NULL
,	NULL
Hall	NULL
A	NULL
and	NULL
Cantrell	NULL
DA	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
6	NULL
,	NULL
1445-1455	NULL
.	NULL

Reif	NULL
KAF	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Department	NULL
of	NULL
Biochemistry	NULL
.	NULL

University	NULL
College	NULL
London	NULL
,	NULL
University	NULL
of	NULL
London	NULL
.	NULL

Rodriguez-Viciana	NULL
P	NULL
,	NULL
Warne	NULL
PH	NULL
,	NULL
Dhand	NULL
R	NULL
,	NULL
Vanhaesbroeck	NULL
B	NULL
,	NULL
Gout	NULL
I	NULL
,	NULL
Fry	NULL
MJ	NULL
,	NULL
Waterfield	NULL
MD	NULL
and	NULL
Downward	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
370	NULL
,	NULL
527-532	NULL
.	NULL

Rodriguez-Viciana	NULL
P	NULL
,	NULL
Warne	NULL
PH	NULL
,	NULL
Khwaji	NULL
A	NULL
,	NULL
Marte	NULL
BM	NULL
,	NULL
Das	NULL
P	NULL
,	NULL
Waterfield	NULL
MD	NULL
,	NULL
Ridley	NULL
A	NULL
and	NULL
Downward	NULL
J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
89	NULL
.	NULL

Rodriguez-Viciana	NULL
P	NULL
,	NULL
Warne	NULL
PH	NULL
,	NULL
Vanhaesebroeck	NULL
B	NULL
,	NULL
Waterfield	NULL
MD	NULL
and	NULL
Downward	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
15	NULL
,	NULL
2442-2451	NULL
.	NULL

Staal	NULL
SP	NULL
and	NULL
Hartley	NULL
JW	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
167	NULL
,	NULL
1259	NULL
1264	NULL
.	NULL

Swan	NULL
KA	NULL
,	NULL
Alberola-Ila	NULL
J	NULL
,	NULL
Gross	NULL
JA	NULL
,	NULL
Appleby	NULL
MW	NULL
,	NULL
Forbush	NULL
KA	NULL
,	NULL
Thomas	NULL
JF	NULL
and	NULL
Perlmutter	NULL
RM	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
14	NULL
,	NULL
276-85	NULL
.	NULL

Swat	NULL
W	NULL
,	NULL
Shinakai	NULL
Y	NULL
,	NULL
Cheng	NULL
H-L	NULL
,	NULL
Davidson	NULL
L	NULL
and	NULL
Alt	NULL
FW	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
,	NULL
93	NULL
,	NULL
4683-4687	NULL
.	NULL

Turner	NULL
H	NULL
and	NULL
Cantrell	NULL
DA	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
185	NULL
,	NULL
43-57	NULL
.	NULL

Wennstrom	NULL
S	NULL
,	NULL
Hawkins	NULL
P	NULL
,	NULL
Cooke	NULL
F	NULL
,	NULL
Hara	NULL
K	NULL
,	NULL
Yonezawa	NULL
K	NULL
,	NULL
Kasuga	NULL
M	NULL
,	NULL
Jackson	NULL
T	NULL
,	NULL
Claesson-Welsh	NULL
L	NULL
and	NULL
Stephens	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
4	NULL
,	NULL
385-393	NULL
.	NULL

Westwick	NULL
JK	NULL
,	NULL
Lambert	NULL
QT	NULL
,	NULL
Clark	NULL
GJ	NULL
,	NULL
Symons	NULL
M	NULL
,	NULL
Van	NULL
Aelst	NULL
L	NULL
,	NULL
Pestell	NULL
RG	NULL
and	NULL
Der	NULL
CJ	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
17	NULL
,	NULL
1324-1335	NULL
.	NULL

Woodrow	NULL
M	NULL
,	NULL
Clipstone	NULL
NA	NULL
and	NULL
Cantrell	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
178	NULL
,	NULL
1517-1522	NULL
.	NULL

Yan	NULL
M	NULL
,	NULL
Dai	NULL
T	NULL
,	NULL
Deak	NULL
J	NULL
,	NULL
Kyriakis	NULL
J	NULL
,	NULL
Zon	NULL
L	NULL
,	NULL
Woodgett	NULL
J	NULL
and	NULL
Templeton	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
372	NULL
,	NULL
798-800	NULL
.	NULL

